BECTON, DICKINSON & CO. (SPARKS) BD PHOENIX PANEL NMIC-306; SYSTEM, TEST, AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY
|
Back to Search Results |
|
Catalog Number 449292 |
Device Problem
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/01/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
H3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported that while testing an e.Coli isolate on the bd phoenix panel nmic-306, ceftazidime-avibactam, ceftolozane-tazobactam, and meropenem were resistant.Also, piperacillin-tazobactam was determined to be intermediate.Confirmatory testing with microscan indicated that all results were sensitive.There was no report of patient impact.
|
|
Search Alerts/Recalls
|
|
|